Heterogalactan WPEP-N-b from Pleurotus eryngii enhances immunity in immunocompromised mice

Int J Biol Macromol. 2023 Jan 15:225:1010-1020. doi: 10.1016/j.ijbiomac.2022.11.163. Epub 2022 Nov 19.

Abstract

This study reports on in vivo immunomodulatory activities mediated by WPEP-N-b, a heterogalactan from Pleurotus eryngii. Using cyclophosphamide (CTX)-induced immunosuppressed mice, we demonstrate here that WPEP-N-b enhances immunity as determined by the immune organ index, peripheral blood immune cell content, splenocyte proliferation, NK cell activity and T lymphocyte subpopulations. WPEP-N-b prevented apoptosis of bone marrow cells induced by CTX. The level of cytokines (i.e. TNF-α, IL-6 and IL-1β) and macrophage activity in these immunocompromised mice were restored upon treated with WPEP-N-b. Mechanistically, it appears that WPEP-N-b enhances splenocyte proliferation and NK cell activity might through the Toll-like receptor 4 (TLR4)-PKC signaling axis, and increases macrophage activity by activating JNK, p38 and NF-κB signaling pathways and Toll-like receptor 2 (TLR2) is the possible receptor of WPEP-N-b in macrophages. Our findings indicate that WPEP-N-b may function as a natural immune stimulant.

Keywords: Cyclophosphamide-induced immunosuppression; Galactans; Immunomodulation; Pleurotus eryngii; Polysaccharides.

MeSH terms

  • Animals
  • Cytokines / metabolism
  • Macrophages* / metabolism
  • Mice
  • NF-kappa B / metabolism
  • Pleurotus* / metabolism

Substances

  • Cytokines
  • NF-kappa B

Supplementary concepts

  • Pleurotus eryngii